Home/Filings/4/0000950103-23-016297
4//SEC Filing

CHASE ADAM 4

Accession 0000950103-23-016297

CIK 0000830524other

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 7:12 PM ET

Size

28.7 KB

Accession

0000950103-23-016297

Insider Transaction Report

Form 4
Period: 2023-11-15
CHASE ADAM
President/COO
Transactions
  • Disposition to Issuer

    Chase Corporation Common Stock

    2023-11-1571,0960 total
  • Disposition to Issuer

    Chase Corporation Common Stock

    2023-11-15154,9270 total(indirect: By Trust)
  • Disposition to Issuer

    Chase Corporation Common Stock

    2023-11-15108,4770 total(indirect: By Trust)
  • Disposition to Issuer

    Stock Options

    2023-11-157,4380 total
    Exercise: $35.50Exp: 2024-08-31Common Stock (7,438 underlying)
  • Disposition to Issuer

    Stock Options

    2023-11-157,2460 total
    Exercise: $39.50Exp: 2025-08-31Common Stock (7,246 underlying)
  • Disposition to Issuer

    Stock Options

    2023-11-1529,1590 total
    Exercise: $64.37Exp: 2026-08-31Common Stock (29,159 underlying)
  • Disposition to Issuer

    Stock Options

    2023-11-154,5910 total
    Exercise: $93.50Exp: 2027-09-01Common Stock (4,591 underlying)
  • Disposition to Issuer

    Stock Options

    2023-11-153,4680 total
    Exercise: $123.95Exp: 2028-09-01Common Stock (3,468 underlying)
  • Disposition to Issuer

    Stock Options

    2023-11-1542,8240 total
    Exercise: $100.22Exp: 2029-09-01Common Stock (42,824 underlying)
  • Disposition to Issuer

    Stock Options

    2023-11-154,1250 total
    Exercise: $97.57Exp: 2030-09-01Common Stock (4,125 underlying)
  • Disposition to Issuer

    Stock Options

    2023-11-153,4740 total
    Exercise: $114.50Exp: 2031-09-01Common Stock (3,474 underlying)
  • Disposition to Issuer

    Stock Options

    2023-11-1511,3670 total
    Exercise: $88.16Exp: 2032-09-01Common Stock (11,367 underlying)
Footnotes (4)
  • [F1]This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger, dated as of July 21, 2023, by and among Chase Corporation (the "Issuer"), Formulations Parent Corporation ("Parent") and Formulations Merger Sub Corporation, a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which, effective as of November 15, 2023 (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each issued and outstanding share of the Issuer's Common Stock (each, a "Share") was cancelled and, except in the case of certain unvested Shares that were forfeited as of the Effective Time or as otherwise agreed between Parent and the holder thereof, was converted into the right to receive $127.50 in cash (the "Per Share Consideration"), subject to any applicable withholding of taxes and without interest.
  • [F2]Represents shares held by the Adam P. Chase Trust.
  • [F3]Represents shares held by the Maria I. Chase Trust.
  • [F4]Represents options to purchase Shares (each, an "Option") held by the Reporting Person. In accordance with the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, became fully vested and was automatically canceled and converted into the right to receive a cash payment, without interest, in an amount equal to the product of (i) the excess, if any, of the Per Share Consideration over the applicable per share exercise price of such Option, multiplied by (ii) the number of shares of Shares issuable in respect of such Option as of immediately prior to the Effective Time, subject to any applicable withholding of taxes.

Issuer

CHASE CORP

CIK 0000830524

Entity typeother

Related Parties

1
  • filerCIK 0001254843

Filing Metadata

Form type
4
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 7:12 PM ET
Size
28.7 KB